Getting Biomarker Testing Right in Non-Small Cell Lung Cancer Care
Project Oncology®Getting Biomarker Testing Right in Non-Small Cell Lung Cancer Care
Raghava Reddy Induru, MD
Choosing the Right Treatment in ALK and ROS1-Positive NSCLC
Project Oncology®Choosing the Right Treatment in ALK and ROS1-Positive NSCLC
Raghava Reddy Induru, MD
Predicting Which Patients Benefit from Biologics in Severe Asthma
Clinician's RoundtablePredicting Which Patients Benefit from Biologics in Severe Asthma
Can microRNAs Predict Steroid Response in Childhood Asthma?
Clinician's RoundtableCan microRNAs Predict Steroid Response in Childhood Asthma?
Ryan Quigley
Geoffrey Chupp, MD
- advertisement
- 3 questions
- advertisement
Targeting Neutrophilic Inflammation in Bronchiectasis: An Emerging Approach
Medical Industry FeatureTargeting Neutrophilic Inflammation in Bronchiectasis: An Emerging Approach
Evaluating EFS and Surgical Outcomes in Resectable NSCLC: Insights From a Clinical Trial
Medical Industry FeatureEvaluating EFS and Surgical Outcomes in Resectable NSCLC: Insights From a Clinical Trial
Shared Decision-Making in Pulmonary Arterial Hypertension: Strategies for PAH Treatment Initiation and Support
Medical Industry FeatureShared Decision-Making in Pulmonary Arterial Hypertension: Strategies for PAH Treatment Initiation and Support
Lori Reed, NP-C
Julie S, patient with PAH
Investigator Perspectives on Treating Patients in a Ph2 NSCLC Trial
Project Oncology®Investigator Perspectives on Treating Patients in a Ph2 NSCLC Trial
Jennifer Caudle, DO, FACOFP
D. Ross Camidge, MD, PhD
Jonathan Goldman, MD
Immune Imprinting and Vaccines: Rethinking the First Exposure to Influenza
Medical Industry FeatureImmune Imprinting and Vaccines: Rethinking the First Exposure to Influenza
- Asthma CSI: Behind the Cytokine Curtain, Part 1: Asthma HQMedical Industry FeatureAsthma CSI: Behind the Cytokine Curtain, Part 1: Asthma HQ
- 05/01/2026
- 05/01/2026
- 04/28/2026
- 04/28/2026
- 04/28/2026
- 04/23/2026